Cancer of unknown primary eventually diagnosed as poorly differentiated prostate cancer: a case report

被引:0
|
作者
Iijima, Kazutaka [1 ,2 ]
Takayama, Toshizo [1 ]
Shindo, Satoko [1 ]
Moku, Rika [1 ]
Sawai, Koya [1 ]
Honma, Rio [1 ]
Hyakushima, Naoki [3 ]
Akino, Tomoshige [4 ]
Oyamada, Yumiko [5 ]
Tsuji, Yasushi [1 ]
机构
[1] Tonan Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan
[2] Rumoi City Hosp, Dept Pathol, Rumoi, Hokkaido 0778511, Japan
[3] Tonan Hosp, Dept Gastroenterol, Sapporo, Japan
[4] Tonan Hosp, Dept Urol, Sapporo, Japan
[5] Tonan Hosp, Dept Pathol, Sapporo, Japan
关键词
Cancer of unknown primary; Prostate cancer; Prostate-specific antigen; Positron emission tomography/computed tomography; Bone metastases; Cervical lymph node metastases; EMISSION-TOMOGRAPHY; ANTIGEN; PSA; ADENOCARCINOMA; MULTICENTER; CARCINOMA;
D O I
10.1186/s13256-023-04118-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundProstate cancer has been well known to have a high prevalence among middle-aged and older men, with high incidence of metastases to the bone-the main metastatic site. However, prostate cancer among those less than 50 years of age is extremely rare, and neck swelling is seldom the initial symptom.Case presentationWe herein report case of a 47-year-old Japanese male with poorly differentiated prostate cancer that had been initially diagnosed as a cancer of unknown primary with multiple lymph node and bone metastases before reaching a definitive diagnosis. The patient has been started on endocrine therapy and is currently alive without progression.Discussion and conclusionWhen locating the primary lesion in men with cancer of unknown primary, it is important to consider the possibility of prostate cancer, confirm serum prostate-specific antigen levels, and perform local prostate evaluation.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Poorly Differentiated Neoplasms of Unknown Primary Site: Diagnostic Usefulness of a Molecular Cancer Classifier Assay
    Greco, F. Anthony
    Lennington, Wayne J.
    Spigel, David R.
    Hainsworth, John D.
    MOLECULAR DIAGNOSIS & THERAPY, 2015, 19 (02) : 91 - 97
  • [22] Poorly Differentiated Neoplasms of Unknown Primary Site: Diagnostic Usefulness of a Molecular Cancer Classifier Assay
    F. Anthony Greco
    Wayne J. Lennington
    David R. Spigel
    John D. Hainsworth
    Molecular Diagnosis & Therapy, 2015, 19 : 91 - 97
  • [23] Sensitivity of prostate specific antigen immunohistochemistry in poorly differentiated prostate cancer
    Varma, M
    Morgan, M
    Tamboli, P
    Jasani, B
    Amin, MB
    LABORATORY INVESTIGATION, 2002, 82 (01) : 185A - 185A
  • [24] Sensitivity of prostate specific antigen immunohistochemistry in poorly differentiated prostate cancer
    Varma, M
    Morgan, M
    Tamboli, P
    Jasani, B
    Amin, MB
    MODERN PATHOLOGY, 2002, 15 (01) : 185A - 185A
  • [25] The Treatment for a Patient with Cancer of Unknown Primary: A Case Report
    Ni, Qingtao
    Lu, Kaijin
    Pan, Chi
    Dai, Shengbin
    Wang, Peng
    DOSE-RESPONSE, 2021, 19 (04):
  • [26] Threat of the spread: renal metastases of poorly differentiated thyroid cancer - a case report
    Lim, Leroy Wui Hon
    Perumal, Kamal Raj
    Goh, Yue Keng
    BJU INTERNATIONAL, 2024, 134 : 19 - 20
  • [27] Is diabetes mellitus associated with poorly differentiated prostate cancer (PCA)?
    Abdollah, F.
    Matloob, R.
    Salonia, A.
    Briganti, A.
    Gallina, A.
    Rigatti, P.
    Montorsi, F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 197 - 197
  • [28] Is diabetes mellitus associated with poorly differentiated prostate cancer (PCa)?
    Abdollah, Firas
    Salonia, Andrea
    Gallina, Andrea
    Scattoni, Vincenzo
    Matloob, Rayan
    Rigatti, Patrizio
    Montorsi, Francesco
    JOURNAL OF UROLOGY, 2008, 179 (04): : 65 - 65
  • [29] Primary poorly differentiated neuroendocrine tumour of the breast: a case report
    Abdessayed, N.
    Bchir, A.
    Chiba, D.
    Nfikha, Z.
    Baccouche, A.
    Mokni, M.
    VIRCHOWS ARCHIV, 2020, 477 : S291 - S292
  • [30] Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: Favorable subsets of patients with unknown-primary carcinoma?
    Lenzi, R
    Hess, KR
    Abbruzzese, MC
    Raber, MN
    Ordonez, NG
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2056 - 2066